Surgical Skill Labs for Robotic Mastectomy and Educational Program Using a Surgical Guide by Artificial Intelligence
Launched by SEVERANCE HOSPITAL · Apr 21, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new educational program designed to help surgeons learn how to perform robotic breast surgery more effectively. The program includes hands-on training using lifelike models, and researchers are also developing an artificial intelligence (AI) surgical guide to assist trainees during their practice. The trial aims to assess how satisfied participants are with the program, how much effort they feel it requires, and how well they perform the surgery before and after the training.
To be eligible for this trial, participants need to be breast surgeons who have completed basic training on the robotic surgery system and must agree to take part by signing a consent form. During the trial, participants will engage in the educational program and complete surveys about their experiences. They will also be evaluated on their surgical skills at the beginning and end of the training. This study is important because it could lead to better training methods for surgeons, ultimately improving patient care in robotic breast surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • A breast surgeon who completed the basic dry lab for surgical robot platform before the educational program
- • A trainee who signed a informed consent
- Exclusion Criteria:
- • A trainee who did not sign a informed consent
- • A trainees judged by the researcher to be inappropriate for participation in this study
About Severance Hospital
Severance Hospital, a leading medical institution affiliated with Yonsei University in South Korea, is committed to advancing healthcare through innovative clinical research. Renowned for its state-of-the-art facilities and multidisciplinary approach, the hospital conducts a wide range of clinical trials aimed at developing novel therapies and improving patient outcomes. With a dedicated team of experienced researchers and healthcare professionals, Severance Hospital prioritizes ethical standards and patient safety, contributing significantly to the global medical community's understanding of various diseases and treatment modalities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Hyung Seok Park, MD, PhD
Principal Investigator
Severance Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported